Cargando…
Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells
BACKGROUND: Ulinastatin or urinary trypsin inhibitor (UTI) has been shown to ameliorate the inflammatory response induced by experimental severe acute pancreatitis (SAP) and hence reduce the mortality, however the mechanism of its action remains incompletely understood. We have investigated the effe...
Autores principales: | Pan, Yu, Fang, Haizong, Lu, Fengchun, Pan, Minggui, Chen, Fei, Xiong, Ping, Yao, Yi, Huang, Heguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360080/ https://www.ncbi.nlm.nih.gov/pubmed/28344516 http://dx.doi.org/10.1186/s12950-017-0154-7 |
Ejemplares similares
-
Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1
por: Pan, Yu, et al.
Publicado: (2019) -
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC
por: Pan, Yu, et al.
Publicado: (2018) -
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
por: Luo, Xin, et al.
Publicado: (2023) -
Efficacy of ulinastatin for the treatment of patients with severe acute pancreatitis
por: Yao, Jian-hui, et al.
Publicado: (2019) -
Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer
por: Pan, Yu, et al.
Publicado: (2019)